On the afternoon of August 16th, a distinguished delegation led by Director Wang Zhuangwu from the Zhejiang Provincial Drug Administration paid a visit to EastPoint Innovation for medical research and inspection. Accompanying Director Wang Zhuangwu were esteemed leaders including Zhou Xuyin, District Mayor of Linping District, Song Bin, Deputy District Mayor of the Standing Committee, Bian Jikun, Director of the Economic and Technological Development Zone, and Feng Shilian, Deputy Director of the Hangzhou Municipal Market Supervision Bureau. Also in attendance were Deputy Director Yu Xiaofen of the Medical Device Department of the Provincial Drug Administration, Director Zhen Hui of the Provincial Medical Device Inspection and Research Institute, and Director Zhou Jie of the Medical Device Department of the Hangzhou Municipal Market Supervision Bureau.

The delegation embarked on a comprehensive tour of EastPoint Innovation's cutting-edge facilities, including the state-of-the-art experimental animal operating room, interventional catheterization (DSA) operating room, CT examination room, new medical technology training operating room furnished with international cutting-edge equipment, and the largest laboratory area in China. Additionally, they explored modern, conceptually advanced technical training areas and academic exchange spaces with a humanistic atmosphere.

Following the tour, the leader of East Point Medical presented a detailed report on the company's core business, technical team, experimental areas, and business development. Notably, East Point Medical's technical team comprises renowned experts sourced domestically and internationally, boasting extensive experience in the medical device industry and animal experimentation, along with professional technical capabilities recognized at an international level. The company is adept at tailoring animal experiments and clinical plans to the specific needs of medical devices and clinical applications. To facilitate original innovation in medical devices, enterprise research and development, and national regulatory compliance, East Point Medical is equipped with top-of-the-line instruments and equipment from leading international brands such as Philips, Alcon, Zeiss, Leica, Hitachi, and Hisense. Since its inception in May, East Point Medical has provided professional preclinical animal testing services to medical device enterprises and research institutions in the province, garnering recognition from national regulatory agencies and customers alike. Presently, negotiations are underway for collaborations with renowned domestic and foreign manufacturers, as well as prestigious research institutions including Peking University and Zhejiang University.

Director Wang Zhuangwu lauded the achievements and positive development trajectory of East Point Medical, highlighting its role as a third-party platform for animal experiments. He emphasized the importance of utilizing advanced inspection, testing, and surgical equipment along with a seasoned technical team to generate professional and authoritative experimental data, essential for endorsement by the National Evaluation Center. Director Wang Zhuangwu underscored the significance of EastPoint Innovation's platform in fostering innovative development within the province's medical device industry through tailored services for innovative products, particularly those of enterprises in Linping District. Regulatory authorities pledged ongoing support for such endeavors.

Expressing gratitude to the Provincial Drug Administration and Linping District for their unwavering support, the leader of EastPoint Innovation reiterated the company's commitment to leveraging its professional advantages and providing high-quality services to advance and supervise the province's medical device industry.